Epsilon Healthcare Limited Logo

Epsilon Healthcare Limited

HDRPF

(0.0)
Stock Price

0,00 USD

-61.84% ROA

-92.15% ROE

-0.05x PER

Market Cap.

7.236.419,19 USD

34.51% DER

0% Yield

-186.84% NPM

Epsilon Healthcare Limited Stock Analysis

Epsilon Healthcare Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Epsilon Healthcare Limited Fundamental Stock Analysis
# Analysis Rating
1 ROE

Unidentified ROE

2 ROA

Unidentified ROA

3 PBV

Unidentified ROA

4 DER

Unidentified DER

5 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

6 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

7 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

8 Graham Number

Unidentified Graham Number

9 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

10 Dividend

The company's decision to withhold dividends for three years raises questions about its ability to generate consistent returns.

11 Buffet Intrinsic Value

The company's stock shows signs of being overvalued (0) according to Warren Buffett's formula, indicating a potential downside as its market price exceeds its estimated intrinsic value.

Epsilon Healthcare Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Epsilon Healthcare Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Buy
4 Stoch RSI Buy

Epsilon Healthcare Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Epsilon Healthcare Limited Revenue
Year Revenue Growth
2016 0
2017 1.902.914 100%
2018 2.664.094 28.57%
2019 4.792.258 44.41%
2020 7.358.888 34.88%
2021 5.498.149 -33.84%
2022 7.112.194 22.69%
2023 6.621.612 -7.41%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Epsilon Healthcare Limited Research and Development Expenses
Year Research and Development Expenses Growth
2016 0
2017 0 0%
2018 41.629 100%
2019 140.297 70.33%
2020 472.257 70.29%
2021 171.097 -176.02%
2022 375.557 54.44%
2023 438.924 14.44%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Epsilon Healthcare Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
2016 386.673
2017 1.725.502 77.59%
2018 4.857.913 64.48%
2019 5.136.647 5.43%
2020 6.954.052 26.13%
2021 6.854.579 -1.45%
2022 3.913.987 -75.13%
2023 420.648 -830.47%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Epsilon Healthcare Limited EBITDA
Year EBITDA Growth
2016 -207.670
2017 -2.474.092 91.61%
2018 -7.212.081 65.7%
2019 -8.776.207 17.82%
2020 -8.779.725 0.04%
2021 -5.493.390 -59.82%
2022 -7.690.290 28.57%
2023 815.936 1042.51%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Epsilon Healthcare Limited Gross Profit
Year Gross Profit Growth
2016 0
2017 837.011 100%
2018 759.758 -10.17%
2019 1.139.638 33.33%
2020 2.661.591 57.18%
2021 2.055.621 -29.48%
2022 1.336.940 -53.76%
2023 4.653.076 71.27%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Epsilon Healthcare Limited Net Profit
Year Net Profit Growth
2016 -212.886
2017 -2.558.525 91.68%
2018 -8.611.270 70.29%
2019 -11.679.182 26.27%
2020 -10.947.661 -6.68%
2021 -8.908.397 -22.89%
2022 -12.677.469 29.73%
2023 -1.434.232 -783.92%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Epsilon Healthcare Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2016 0
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Epsilon Healthcare Limited Free Cashflow
Year Free Cashflow Growth
2016 -147.809
2017 -2.535.835 94.17%
2018 -8.881.481 71.45%
2019 -8.570.124 -3.63%
2020 -9.929.537 13.69%
2021 -6.177.127 -60.75%
2022 -3.100.053 -99.26%
2023 -247.812 -1150.97%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Epsilon Healthcare Limited Operating Cashflow
Year Operating Cashflow Growth
2016 -147.809
2017 -1.877.919 92.13%
2018 -5.850.105 67.9%
2019 -7.855.445 25.53%
2020 -8.693.782 9.64%
2021 -5.429.416 -60.12%
2022 -2.570.652 -111.21%
2023 -247.812 -937.34%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Epsilon Healthcare Limited Capital Expenditure
Year Capital Expenditure Growth
2016 0
2017 657.916 100%
2018 3.031.376 78.3%
2019 714.679 -324.16%
2020 1.235.755 42.17%
2021 747.711 -65.27%
2022 529.401 -41.24%
2023 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Epsilon Healthcare Limited Equity
Year Equity Growth
2016 11.343.289
2017 21.357.900 46.89%
2018 28.087.949 23.96%
2019 22.321.180 -25.84%
2020 25.319.065 11.84%
2021 19.571.142 -29.37%
2022 9.269.896 -111.13%
2023 9.161.475 -1.18%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Epsilon Healthcare Limited Assets
Year Assets Growth
2016 11.460.283
2017 21.946.725 47.78%
2018 32.746.412 32.98%
2019 27.813.404 -17.74%
2020 37.262.869 25.36%
2021 30.552.121 -21.96%
2022 20.499.958 -49.04%
2023 17.818.885 -15.05%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Epsilon Healthcare Limited Liabilities
Year Liabilities Growth
2016 116.994
2017 588.825 80.13%
2018 4.658.463 87.36%
2019 5.492.224 15.18%
2020 11.943.804 54.02%
2021 10.980.979 -8.77%
2022 11.230.062 2.22%
2023 8.657.410 -29.72%

Epsilon Healthcare Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.02
Net Income per Share
-0.04
Price to Earning Ratio
-0.05x
Price To Sales Ratio
1.02x
POCF Ratio
-0.24
PFCF Ratio
-2.33
Price to Book Ratio
0.07
EV to Sales
1.35
EV Over EBITDA
-1.24
EV to Operating CashFlow
-3.72
EV to FreeCashFlow
-3.09
Earnings Yield
-20.3
FreeCashFlow Yield
-0.43
Market Cap
0,01 Bil.
Enterprise Value
0,01 Bil.
Graham Number
0.17
Graham NetNet
-0.03

Income Statement Metrics

Net Income per Share
-0.04
Income Quality
0.19
ROE
-0.88
Return On Assets
-0.65
Return On Capital Employed
-0.64
Net Income per EBT
1
EBT Per Ebit
1.66
Ebit per Revenue
-1.12
Effective Tax Rate
0

Margins

Sales, General, & Administrative to Revenue
0.55
Research & Developement to Revenue
0.05
Stock Based Compensation to Revenue
0
Gross Profit Margin
-0.43
Operating Profit Margin
-1.12
Pretax Profit Margin
-1.87
Net Profit Margin
-1.87

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.01
Free CashFlow per Share
-0.01
Capex to Operating CashFlow
-0.21
Capex to Revenue
0.07
Capex to Depreciation
0.29
Return on Invested Capital
-0.82
Return on Tangible Assets
-0.62
Days Sales Outstanding
161.4
Days Payables Outstanding
294.1
Days of Inventory on Hand
38.62
Receivables Turnover
2.26
Payables Turnover
1.24
Inventory Turnover
9.45
Capex per Share
0

Balance Sheet

Cash per Share
0,00
Book Value per Share
0,03
Tangible Book Value per Share
0.03
Shareholders Equity per Share
0.03
Interest Debt per Share
0.01
Debt to Equity
0.35
Debt to Assets
0.16
Net Debt to EBITDA
-0.3
Current Ratio
0.6
Tangible Asset Value
0,01 Bil.
Net Current Asset Value
-0,01 Bil.
Invested Capital
12451435
Working Capital
0,00 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
1515717.5
Debt to Market Cap
0.44

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Epsilon Healthcare Limited Dividends
Year Dividends Growth

Epsilon Healthcare Limited Profile

About Epsilon Healthcare Limited

Epsilon Healthcare Limited operates as a healthcare and pharmaceuticals company primarily in Australia and Canada. It engages in the manufacture and distribution of hydroponics equipment, materials, and nutrients; and development and delivery of medicinal cannabis, as well as provides turnkey cannabis cultivation solutions. The company was formerly known as THC Global Group Limited and changed its name to Epsilon Healthcare Limited in February 2021. Epsilon Healthcare Limited was incorporated in 2016 and is based in Sydney, Australia.

CEO
Mr. Daniel Sanghera
Employee
0
Address
9 Castlereagh Street
Sydney, 2000

Epsilon Healthcare Limited Executives & BODs

Epsilon Healthcare Limited Executives & BODs
# Name Age
1 Mr. Daniel Sanghera
Interim Chief Executive Officer
70
2 Ms. Diandra Phipps
Chief Operating Officer of Tetra Health
70
3 Ms. Li Lin
Group Financial Controller
70

Epsilon Healthcare Limited Competitors